Access to cannabis for medical and scientific purposes RIS

cannabis stocks have endured a significant decline. with cannabis-related companies correcting an average of 29% and speculative cannabis companies dropping 49%. RECENT NEWS. Third Quarter Financial Results. In the third quarter of 2018, sales increased 109%. to approximately $8.41 million versus $4.03 million during the comparable quarter in 2017. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download